HAE — Haemonetics Corporation stock price, charts and financials

QT65Haemonetics Corporation

Haemonetics Corporation (NYSE: HAE) is a Healthcare company in the Medical - Devices industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
85.38
-1.41-1.62%
OverviewShort InterestFilings
HAEQT65Haemonetics Corporation·NYSE
85.38-1.62%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 28, 20268-KCurrent report
Jul 28, 20264Statement of changes in beneficial ownership
Jul 28, 20264Statement of changes in beneficial ownership
Jul 28, 20264Statement of changes in beneficial ownership
Jul 28, 20263Initial statement of beneficial ownership
Jul 28, 20264Statement of changes in beneficial ownership
Jul 28, 20264Statement of changes in beneficial ownership
Jul 28, 20264Statement of changes in beneficial ownership
Jul 28, 20264Statement of changes in beneficial ownership
Jul 28, 20264Statement of changes in beneficial ownership
Jun 09, 2026DEFA14AAdditional proxy soliciting materials
Jun 09, 2026ARSAnnual report to shareholders
Jun 09, 2026DEF 14ADefinitive proxy statement
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 05, 20268-KCurrent report
May 28, 2026SDSpecialized disclosure report
May 20, 202610-KAnnual report
May 19, 20264Statement of changes in beneficial ownership
May 19, 20264Statement of changes in beneficial ownership
May 19, 20264Statement of changes in beneficial ownership
May 19, 20264Statement of changes in beneficial ownership
May 19, 20264Statement of changes in beneficial ownership
May 19, 20264Statement of changes in beneficial ownership
May 19, 20264Statement of changes in beneficial ownership
#1 / 25 of 326
Page
▼
/ 14